期刊文献+

细胞因子反应调节蛋白A对软骨细胞白细胞介素-1β转化酶表达的作用研究 被引量:1

Effect of cytokine response modifier A on the expression of interleukin-1β converting enzyme in chondrocytes
原文传递
导出
摘要 目的探讨壳聚糖(cs)介导细胞因子反应调节蛋白A(CrmA)对软骨细胞IL-1β转化酶(ICE)和IL-1β mRNA和蛋白的表达作用。方法体外培养兔关节软骨细胞,分别加入PBS、10μg/mlCS/pcDNA3.1(+)和cs/r,cDNA3.1(+)CrmA处理后,加入10ng/ml IL-1β共培养,采用实时定量PCR方法检测软骨细胞ICE和IL-1β mRNA的表达。蛋白印迹法分析软骨细胞ICE和IL-1β蛋白的表达。结果ICEmRNA在Cs/pcDNA3.1(+)CrmA组(0.52±0.09)软骨细胞中的表达显著低于CS/pcDNA3.1(+)组(0.84±0.11,t=4.42,P〈0.01)和PBS组(1.00±0.10,t=6.58,P〈0.01),软骨细胞ICE蛋白在CS/pcDNA3.1(+)CrmA组(0.20±0.03)的表达明显低于CS/pcDNA3.1(+)组(0.37±0.05,f=4.85,P〈0.01)和PBS组(0.44±0.07,t=6.68,P〈0.01),cs/pcDNA3.1(+)组软骨细胞ICEmRNA和蛋白的表达与PBS组比较差异无统计学意义。与CS/pcDNA3.1(+)组(0.69±0.06,t=3.50,P〈0.01)和PBS(0.99±0.04,t=11.12,P〈0.01)组比较,cs/pcDNA3.1(+)CrmA组软骨细胞IL-1β t=3.50,(0.55±0.08)mRNA表达明显降低。软骨细胞IL-1β蛋白的表达在CS/pcDNA3.1(+)CrmA组(0.230±0.020)显著低于CS/pcDNA3.1(+)组(0.450±0.060,t=5.07,P〈0.01)与PBS组(0.610±0.090,t=8.70,P〈0.01),cs/pcDNA3.1(+)组与PBS组比较软骨细胞IL-1β mRNA和蛋白的表达差异有统计学意义(t=7.61,P〈0.01;f=3.63,P〈0.01)。结论壳聚糖介导CrmA能够显著抑制ICEmRNA和蛋白的表达,从而下调IL-1β mRNA和蛋白的表达,这可能成为CS/pcDNA3.1(+)CrmA抑制OA软骨退变的作用机制之一。 Objective To investigate the effects of chitosan(CS)/pcDNA3.1(+) CrmA on the expression of interleukin-1β (IL-1β) converting enzyme (ICE) and IL-1β in chondrocytes. Methods Rabbit chondrocytes were isolated and cultured. Chondrocytes were treated with PBS, 10 μg/ml CS/pcDNA3.1 (+) and CS/pcDNA3.1 (+) CrmA respectively for 6 hours. Then 10 ng/ml IL-1β was added into the culture medium. After 48 hours, the messenger RNA and protein expression of ICE and IL-1β in chondrocytes were detected by using real time polymerase chain reaction and western blotting. Results In CS/pcDNA3.1 (+) CrmA treated group (0.52 ±0.09), the mRNA expression of ICE inchondrocytes was significantly inhibited compared withcorresponding samples of CS/pcDNA3.1(+) group (0.84±0.11, t=4.42, P〈0.01) and PBS group (1.00±0.10, t=6.58, P〈0.01). ICE protein expression in CS/pcDNA3.1(+) CrmA treated group (0.20±0.03) was markedly lower than CS/pcDNA3.1 (+) (0.37±0.05, t=4.85, P〈0.01) and PBS treated group (0.44±0.07, t=6.68, P〈0.01). There was no significant difference of ICE mRNA and protein expressions in chondrocytes between CS/pcDNA3.1(+) group and PBS group. Significant difference of IL-1β mRNA expression was found in the three groups. IL-1β mRNA expression level was significantly lower in CS/peDNA3.1(+) CrmA treated group (0.55± 0.08) than CS/pcDNA3.1(+) (0.69±0.06, t=3.50, P〈0.01) and PBS group (0.99±0.04, t=11.12, P〈0.01)of chondrocytes. IL-1β protein expression level of chondrocytesin CS/pcDNA3.1(+) CrmA group (0.230±0.020) was significantly lower than CS/peDNA3.1 (+) (0.450±0.060, t=5.07, P〈0.01 )and PBS groups (0.610±0.090, t=8.70, P〈0.01) of eells. Significant differenee of IL-1β mRNA and protein expression between CS/peDNA3.1 (+) and PBS group was also observed (t=7.61, P〈0.01; t=3.63, P〈0.01). Conclusion CrmA mediated by ehitosan ean signifieantly suppress t
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2016年第9期609-613,共5页 Chinese Journal of Rheumatology
基金 国家自然科学基金(81071494) 中央高校基本科研业务费专项资金项目(2042015kf10-14) 湖北省科技支撑计划项目(2015BCA316) 湖北省卫生计生科研项目(WJ2015MB024)
关键词 软骨细胞 半胱氨酸天冬氨酸蛋白酶1 细胞因子反应调节蛋白A Chondrocytes Caspase 1 Cytokine response modifier A
  • 相关文献

参考文献2

二级参考文献84

  • 1郁时兵,赵霞,傅欣,武凤兰,张继英,毛泽斌,于长隆.壳聚糖载体介导的骨关节炎基因治疗[J].中国运动医学杂志,2006,25(2):133-137. 被引量:3
  • 2陈庆,刘世清,杜予民,彭昊,余洋,孙立苹.羧甲基壳聚糖抑制白细胞介素-1β诱导的软骨细胞凋亡及作用机制的研究[J].中华风湿病学杂志,2006,10(6):342-344. 被引量:3
  • 3Fujino M, Kawasaki M, Funeshima N, et al. CrmA gene expres- sion protects mice against concanavalin-A-induced hepatitis by inhibiting IL-18 secretion and hepatocyte apoptosis. C, en Ther, 2003, 10: 1781-1790. 被引量:1
  • 4Ekert PG, Silke J, David L, et al. Inhibition of apoptosis and clonogenic survival of ceils expressing crmA variants: optima] caspase substrates are not necessarily optimal inhibitors. EMBO J, 1999, 18: 330-338. 被引量:1
  • 5Lu HD, Zhao HQ, Wang K, et al. Novel hyalumnie acidchi- tosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int J Pharm, 2011, 420: 358-365. 被引量:1
  • 6Santangelo KS, Nuovo GJ, Bertone AL In vivo reduction or blockade of interleukin-ll5 in primary osteoarteoarthritis influences expression of mediators implicated in pathogenesis. Osteoarthritis Cartilage, 2012, 20: 1610-1618. 被引量:1
  • 7Jotanovie Z, Mihelie R, Sestan B, et al. Role of interteukin-1 inhibitors in osteoarthritis: an evidence-based review. Drugs Artg, 2012, 29: 343-358. 被引量:1
  • 8Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for tar- geted delivery of small interfering RNA. hat J Pharm, 2010, 399: 1-11. 被引量:1
  • 9Saha N, Moldovan F, Tardif G, et al. Interleukin-lbeta-convert- ing enzyme/caspase-1 in humarl osteoal-thrific tissues: localization and role in the maturation d interleukin-lheta and interleukin- 18. Arthritis Rheum, 1999, 42: 1577-1587. 被引量:1
  • 10Krautwald S, Ziegler E, Rolver L, et al. Effective blockage of both the extrinsic and intrinsic pathways of apoptosis in mice by TAT-crmA. J Biol Chem, 2010, 285: 19997-20005. 被引量:1

共引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部